Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Primatene Mist
- Development stage
- Approved
- Lead developer
- Amphastar Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Inhalation
01
Overview
Primatene Mist is an over-the-counter (OTC) bronchodilator spray containing epinephrine as the active ingredient. It is used for temporary relief of mild symptoms of intermittent asthma, such as wheezing, shortness of breath, and tightness in the chest. The medication works as an alpha and beta adrenergic agonist, attaching to receptors that cause lung muscles to relax and airways to open.
- Brand names
- Primatene Mist
- Other names
- epinephrine
02
Targets
ADRA1A (α1A)ADRA2A (α2A)ADRB2 (β2)ADRB1 (β1)
Beyond the preview
Go deeper on Primatene Mist.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Primatene Mist.